SOLIS PHARMS
GenericsSOLIS PHARMS is a generic drug manufacturer focused on Dermatology.
SOLIS PHARMS's Key Drugs
SOLIS PHARMS's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
SOLIS PHARMS's Recent FDA Approvals
New NDA/BLA approvals for SOLIS PHARMS over the last two years — novel drugs only, excluding generics and label supplements.
SOLIS PHARMS's Therapeutic Areas
SOLIS PHARMS's approved drugs and pipeline span 1 therapeutic area, led by Dermatology, across 0 biologic and 0 small-molecule drugs. Weighted by commercial stage — approved drugs count most, then late-stage trials.
SOLIS PHARMS's Top Competitors
SOLIS PHARMS's closest competitors by therapeutic-area and drug-target overlap include Pfizer, Baxter, and Eli Lilly. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
SOLIS PHARMS Pipeline Snapshot
Active clinical trials for SOLIS PHARMS across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Dermatology pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1979-01-26
- Latest
- 2025-04-23
- Applications
- 5